Schedule 13G ownership disclosure
EVELO BIOSCIENCES INC
Security class unavailable · CUSIP: 299734202
Event date: 2023-07-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-23-020434
- Form type
- SC 13G
- Filer
- Evelo Biosciences, Inc.
- CIK
- CIK 1694665
- Filed
- Jul 21, 2023
- Reporting period
- Jul 11, 2023
- Description
- Schedule 13G beneficial ownership